NASDAQ:GENE - Genetic Technologies Stock Price, Price Target & More

$1.3234 -0.02 (-1.49 %)
(As of 04/22/2018 04:00 PM ET)
Previous Close$1.3234
Today's Range$1.30 - $1.35
52-Week Range$0.70 - $2.05
Volume49,989 shs
Average Volume71,302 shs
Market Capitalization$21.49 million
P/E RatioN/A
Dividend YieldN/A
Beta3.37

About Genetic Technologies (NASDAQ:GENE)

Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage the women's health. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons primarily in Australia and the United States. The company has research and services agreement with The University of Melbourne for the development and enhancement of the BREVAGenplus breast cancer risk assessment test. Genetic Technologies Limited was founded in 1989 and is headquartered in Fitzroy, Australia.

Receive GENE News and Ratings via Email

Sign-up to receive the latest news and ratings for GENE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:GENE
CUSIPN/A
Phone61-3-8412-7000

Debt

Debt-to-Equity RatioN/A
Current Ratio7.02%
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$390,000.00
Price / Sales55.11
Cash FlowN/A
Price / CashN/A
Book Value$0.49 per share
Price / Book2.70

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees20
Outstanding Shares16,240,000

How to Become a New Pot Stock Millionaire

Genetic Technologies (NASDAQ:GENE) Frequently Asked Questions

What is Genetic Technologies' stock symbol?

Genetic Technologies trades on the NASDAQ under the ticker symbol "GENE."

Who are some of Genetic Technologies' key competitors?

Who are Genetic Technologies' key executives?

Genetic Technologies' management team includes the folowing people:
  • Dr. Paul Alexander Kasian Ph.D., Chairman & Acting CEO (Age 61)
  • Mr. Kevin Fischer CPA, AGIA, ACIS, B.Com., CFO & Company Sec.
  • Dr. Richard Allman Ph.D., Scientific Director (Age 58)
  • Ms. Diana Newport, Quality & Bus. Operations Director (Age 61)
  • Ms. Bronwyn M. Christie B.Com., CPA, Grd Dip C.G., Financial Controller

Has Genetic Technologies been receiving favorable news coverage?

News headlines about GENE stock have trended somewhat positive recently, Accern Sentiment reports. The research group identifies negative and positive press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Genetic Technologies earned a daily sentiment score of 0.16 on Accern's scale. They also assigned media headlines about the biotechnology company an impact score of 47.19 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

How do I buy shares of Genetic Technologies?

Shares of GENE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Genetic Technologies' stock price today?

One share of GENE stock can currently be purchased for approximately $1.3234.

How big of a company is Genetic Technologies?

Genetic Technologies has a market capitalization of $21.49 million and generates $390,000.00 in revenue each year. Genetic Technologies employs 20 workers across the globe.

How can I contact Genetic Technologies?

Genetic Technologies' mailing address is 60-66 HANOVER STREET, FITZROY C3, 3065. The biotechnology company can be reached via phone at 61-3-8412-7000 or via email at [email protected].com.


MarketBeat Community Rating for Genetic Technologies (GENE)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  59 (Vote Outperform)
Underperform Votes:  66 (Vote Underperform)
Total Votes:  125
MarketBeat's community ratings are surveys of what our community members think about Genetic Technologies and other stocks. Vote "Outperform" if you believe GENE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GENE will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Genetic Technologies (NASDAQ:GENE) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/22/2016 forward)

Earnings

Dividends

Genetic Technologies (NASDAQ:GENE) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Genetic Technologies (NASDAQ GENE) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 6.48%
Insider Trading History for Genetic Technologies (NASDAQ:GENE)

Genetic Technologies (NASDAQ GENE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Genetic Technologies (NASDAQ GENE) News Headlines

Source:
DateHeadline
These former SpaceX engineers are helping scientists find cures for genetic diseasesThese former SpaceX engineers are helping scientists find cures for genetic diseases
www.cnbc.com - April 20 at 9:22 AM
Taconic Biosciences Licenses Easi-CRISPR Technology from the University of NebraskaTaconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska
globenewswire.com - April 20 at 9:22 AM
These ex-SpaceX engineers are helping scientists find cures for genetic diseasesThese ex-SpaceX engineers are helping scientists find cures for genetic diseases
uk.finance.yahoo.com - April 19 at 4:50 PM
Gates backs gene technologies in fight to end malariaGates backs gene technologies in fight to end malaria
www.reuters.com - April 18 at 4:55 PM
True Health Launches New Genetic Carrier ScreeningTrue Health Launches New Genetic Carrier Screening
www.bizjournals.com - April 16 at 4:36 PM
Employees Jump at Genetic Testing. Is That a Good Thing?Employees Jump at Genetic Testing. Is That a Good Thing?
www.nytimes.com - April 16 at 9:06 AM
Bill Gates says it would be a tragedy to pass up a controversial, revolutionary gene-editing technologyBill Gates says it would be a 'tragedy' to pass up a controversial, revolutionary gene-editing technology
www.msn.com - April 14 at 9:21 AM
A controversial technology could save us from starvation — if we let itA controversial technology could save us from starvation — if we let it
www.businessinsider.com - April 12 at 4:41 PM
Global Direct-to-Consumer Genetic Health Testing Market Report 2018Global Direct-to-Consumer Genetic Health Testing Market Report 2018
globenewswire.com - April 12 at 10:00 AM
Estonia offers free genetic testing in nationwide experimentEstonia offers free genetic testing in nationwide experiment
abcnews.go.com - April 12 at 10:00 AM
Belgium Infectious Disease Testing Market 2018-2023 - Current & Emerging Products, Technology Review and Opportunities - ResearchAndMarkets.comBelgium Infectious Disease Testing Market 2018-2023 - Current & Emerging Products, Technology Review and Opportunities - ResearchAndMarkets.com
www.finanznachrichten.de - April 10 at 4:41 PM
Can the Gene-Editing Technology CRISPR Cure This Debilitating Brain Disease?Can the Gene-Editing Technology CRISPR Cure This Debilitating Brain Disease?
www.msn.com - April 10 at 4:41 PM
Mars Petcare Acquisition of OptiGen, LLC Will Enable Discovery of New Genetic Health Markers for DogsMars Petcare Acquisition of OptiGen, LLC Will Enable Discovery of New Genetic Health Markers for Dogs
www.prnewswire.com - April 10 at 4:41 PM
Wave Life Sciences and Deep Genomics Form Collaboration to Discover Novel Therapies for Genetic Neuromuscular DisordersWave Life Sciences and Deep Genomics Form Collaboration to Discover Novel Therapies for Genetic Neuromuscular Disorders
globenewswire.com - April 10 at 9:37 AM
Counsyl Highlights Importance of Patient Access to Genetic Testing at the 2018 ACMG Annual Clinical Genetics MeetingCounsyl Highlights Importance of Patient Access to Genetic Testing at the 2018 ACMG Annual Clinical Genetics Meeting
www.businesswire.com - April 5 at 9:19 AM
Study begins to reveal genetic ties behind a neurological phenomenonStudy begins to reveal genetic ties behind a neurological phenomenon
www.msn.com - March 31 at 4:41 PM
Laboratory for Advanced Medicine Provides Select Doctors with Revolutionary New IvyGene Technology for Early Cancer Diagnosis and DetectionLaboratory for Advanced Medicine Provides Select Doctors with Revolutionary New IvyGene Technology for Early Cancer Diagnosis and Detection
www.bizjournals.com - March 26 at 9:37 AM
Global Genetic Disorders Partnering 2012-2018: Deal Trends, Players and Financials - ResearchAndMarkets.comGlobal Genetic Disorders Partnering 2012-2018: Deal Trends, Players and Financials - ResearchAndMarkets.com
www.bizjournals.com - March 24 at 4:35 PM
Invictus MD Strategies Corp. Opens the MarketInvictus MD Strategies Corp. Opens the Market
finance.yahoo.com - March 20 at 4:33 PM
Genetic Technologies Limited (GENE) Short Interest UpdateGenetic Technologies Limited (GENE) Short Interest Update
www.americanbankingnews.com - March 14 at 1:38 AM
Genetic tweak makes plants use 25% less waterGenetic tweak makes plants use 25% less water
www.msn.com - March 7 at 9:21 AM
Genetic Tech to team up with Project Shivom to create large genetic databaseGenetic Tech to team up with Project Shivom to create large genetic database
seekingalpha.com - March 7 at 9:21 AM
Shivom Partnership With Genetic Technologies Will Enable Better Cancer Prediction and Prevention Through Mass Genomic Data AnalysisShivom Partnership With Genetic Technologies Will Enable Better Cancer Prediction and Prevention Through Mass Genomic Data Analysis
finance.yahoo.com - March 6 at 4:59 PM
Genetic Technologies Limited: Project Shivom Strategic AllianceGenetic Technologies Limited: Project Shivom Strategic Alliance
finance.yahoo.com - March 6 at 9:06 AM
Genetic Technologies Announces Strategic Alliance and Capital RaisingGenetic Technologies Announces Strategic Alliance and Capital Raising
finance.yahoo.com - February 23 at 9:09 AM
Change of Chief Executive OfficerChange of Chief Executive Officer
finance.yahoo.com - February 6 at 9:17 AM
Trial by fire: Two Cambridge biotechs race to find a gene therapy cure for DuchenneTrial by fire: Two Cambridge biotechs race to find a gene therapy cure for Duchenne
www.bizjournals.com - February 1 at 4:16 PM
Results from 31 January 2018 General MeetingResults from 31 January 2018 General Meeting
finance.yahoo.com - January 31 at 9:39 AM
BRIEF-Genetic Technologies Seeks Trading HaltBRIEF-Genetic Technologies Seeks Trading Halt
www.reuters.com - January 30 at 4:19 PM
Will Technology In Healthcare Make The Rich Healthier And The Poor Sicker?Will Technology In Healthcare Make The Rich Healthier And The Poor Sicker?
www.forbes.com - January 30 at 4:19 PM
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 December 2017Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 December 2017
finance.yahoo.com - January 29 at 9:27 AM
Genetic Technologies Limited (GENE) Short Interest Up 67.9% in JanuaryGenetic Technologies Limited (GENE) Short Interest Up 67.9% in January
www.americanbankingnews.com - January 28 at 2:34 AM
The Market for Direct-to-Consumer Genetic Health Testing, with Key Focus on Quest Diagnostics and LabCorpThe Market for Direct-to-Consumer Genetic Health Testing, with Key Focus on Quest Diagnostics and LabCorp
www.finanznachrichten.de - January 19 at 10:24 AM
Genetic Technologies Regains Nasdaq Listing ComplianceGenetic Technologies Regains Nasdaq Listing Compliance
finance.yahoo.com - January 9 at 9:23 AM
MediSapiens Joins the FinnGen Project and Brings Solutions to Curation, Management and Visualization of Genetic and Clinical Data of 500.000 FinnsMediSapiens Joins the FinnGen Project and Brings Solutions to Curation, Management and Visualization of Genetic and Clinical Data of 500.000 Finns
www.bizjournals.com - December 23 at 8:06 PM
Global Recombinant DNA (rDNA) Technology Market Report, Size, Share, Analysis 2017 and Forecast to 2023Global Recombinant DNA (rDNA) Technology Market Report, Size, Share, Analysis 2017 and Forecast to 2023
www.marketwatch.com - October 31 at 8:11 PM
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing RulesGenetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules
www.nasdaq.com - October 30 at 7:52 PM
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 September 2017Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 September 2017
finance.yahoo.com - October 30 at 7:52 PM
Antibody Drugs: Technologies and Global MarketsAntibody Drugs: Technologies and Global Markets
www.bizjournals.com - October 10 at 4:43 PM
Todays Research Reports on Stocks to Watch: Tetraphase Pharmaceuticals and Genetic TechnologiesToday's Research Reports on Stocks to Watch: Tetraphase Pharmaceuticals and Genetic Technologies
finance.yahoo.com - October 5 at 8:34 AM
A Moral Duty To AbortA Moral Duty To Abort
www.huffingtonpost.com - September 23 at 5:46 AM
Genetic Technologies Transitions to Online Commercial Platform for BREVAGenplus®Genetic Technologies Transitions to Online Commercial Platform for BREVAGenplus®
finance.yahoo.com - September 22 at 2:35 PM
Global Industrial Enzyme Market Growth Estimated At CAGR Of 5.8% For The Forecast Period 2016-2023: Occams Business Research & Consulting Pvt. Ltd.Global Industrial Enzyme Market Growth Estimated At CAGR Of 5.8% For The Forecast Period 2016-2023: Occams Business Research & Consulting Pvt. Ltd.
www.thestreet.com - September 13 at 5:51 AM
Genetic Technologies Ltd. :GENE-US: Earnings Analysis: For the six months ended June 30, 2017 : September 1, 2017Genetic Technologies Ltd. :GENE-US: Earnings Analysis: For the six months ended June 30, 2017 : September 1, 2017
finance.yahoo.com - September 1 at 7:21 PM
Benitec Biopharmas (BNIKF) CEO Greg West on Q2 2017 Results - Earnings Call TranscriptBenitec Biopharma's (BNIKF) CEO Greg West on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 31 at 3:54 AM
Genetic Technologies Announces Comprehensive Review of Strategic AlternativesGenetic Technologies Announces Comprehensive Review of Strategic Alternatives
finance.yahoo.com - August 25 at 5:47 AM
Silicon Valley Startup Grail Sees Hope for Cancer Blood TestSilicon Valley Startup Grail Sees Hope for Cancer Blood Test
www.bloomberg.com - August 9 at 7:09 PM
Inside the Secret World of Global Food SpiesInside the Secret World of Global Food Spies
www.bloomberg.com - August 7 at 4:17 PM
Research Published in Molecular Therapy Identifies Optimal Gene-based Therapeutic Construct for X-Linked Retinitis PigmentosaResearch Published in Molecular Therapy Identifies Optimal Gene-based Therapeutic Construct for X-Linked Retinitis Pigmentosa
globenewswire.com - August 7 at 4:17 PM
DVAX Plunges On Delay In Approval, FDA Nod For ABBVs HCV Drug, ABIO On RadarDVAX Plunges On Delay In Approval, FDA Nod For ABBV's HCV Drug, ABIO On Radar
www.rttnews.com - August 5 at 12:18 AM

SEC Filings

Genetic Technologies (NASDAQ:GENE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Genetic Technologies (NASDAQ:GENE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Genetic Technologies (NASDAQ GENE) Stock Chart for Sunday, April, 22, 2018

Loading chart…

This page was last updated on 4/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.